Navigation Links
Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.
Date:11/26/2014

BOCA RATON, Fla., Nov. 25, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product ANDA agreement with Pii (Pharmaceutics International, Inc.) (Hunt Valley, Maryland) under which Breckenridge and Pii expect to develop and commercialize several new ANDA's.  Under the terms of the agreement, Pii will develop, manufacture and supply the products, and Breckenridge will market and distribute the products under its own label.  The drugs, comprised of four unique dosage forms, and have combined U.S. market sales in excess of $1.6B, in the 12-month period ending September 30, 2014.  The multi-product agreement contemplates the submission of multiple ANDA's with Paragraph IV certifications.    

About Breckenridge:

Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products in many therapeutic categories.  The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide.  The company markets over 60 products in a variety of dosage forms and therapeutic categories. To date through 2014, Breckenridge has filed 23 ANDA's with Paragraph IV patent challenges.
www.bpirx.com

About Pharmaceutics International, Inc.:

Pii (Pharmaceutics International, Inc.) is a privately held drug delivery solutions company providing dosage form development and GMP Manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley Maryland USA with European development and manufacturing facilities in the UK, Pii offers preformulation testing, formulation development and clinical trial material and commercial manufacture of parenteral, solid, semi-solid and liquid dosage forms.
www.pharm-int.com


'/>"/>
SOURCE Breckenridge Pharmaceutical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics
2. Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics
3. Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macovens Discontinuance of Certain Products
4. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
5. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
6. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
7. Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
8. Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants
9. Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
10. Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market
11. Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... December 05, 2018 , ... NDA Partners Chairman ... Director of Global Laboratory Integration at the United States Pharmacopeial Convention (USP), has ... executive with extensive experience in domestic and international operations harmonization, compendial affairs, and ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for ... the launch of the Annatto-E™ product line, containing unique and natural vitamin E ... research, DFH’s new Annatto-E™ products are available in three dosages of 75mg (with ...
(Date:11/29/2018)... ... November 29, 2018 , ... Windsor Gardens Healthcare Center of the Valley (“Windsor ... announced today they were selected by the California Association of Health Facilities (CAHF) as ... Project. , The California Department of Public Health awarded a grant of $700,000 ...
Breaking Medicine Technology:
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced Clinical, a clinical ... new office location in Paris, France during the Partnerships in Clinical Trials Europe ... Europe and additional in-country personnel. , “The new office broadens our CRO and ...
(Date:12/5/2018)... ... December 05, 2018 , ... Dr. Jessica Allen of Northern Colorado Periodontics is ... ailing dental implants in the Fort Collins area. Dr. Allen joins an elite class ... bone and tissues lost to gum disease. , "Gum disease is a problem that ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... ... philosophy reinforces the theme of Unitek’s transformative conference at the DoubleTree Hilton Hotel ... FAAN, LL (AAN), Distinguished Professor and Founder/Director of Watson Caring Science Institute, participants ...
(Date:11/29/2018)... , ... November 29, 2018 ... ... published and released last month in the journal BMC Infectious Diseases published ... bins are crawling with infectious viruses that can cause serious and in ...
(Date:11/28/2018)... ... 28, 2018 , ... Melania Trump, first lady of the United States, took ... event addressing the national opioid epidemic. The event was filmed for the pilot episode ... to an accidental opioid overdose last year. The program is scheduled to air nationally ...
Breaking Medicine News(10 mins):